Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2432994-31-3
2. Kt-474
3. Kt474
4. N-[3-(difluoromethyl)-1-[trans-4-[[4-[[3-[1-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-3-methyl-2-oxo-1h-benzimidazol-4-yl]-2-propyn-1-yl]oxy]-1-piperidinyl]methyl]cyclohexyl]-1h-pyrazol-4-yl]-5-(1r,4r)-2-oxa-5-azabicyclo[2.2.1]hept-5-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide
5. N-[3-(difluoromethyl)-1-[4-[[4-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]prop-2-ynoxy]piperidin-1-yl]methyl]cyclohexyl]pyrazol-4-yl]-5-[(1r,4r)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
6. 2sxr65p7e3
7. Schembl21998241
8. Schembl23807243
9. Schembl25986139
10. Gtpl12892
11. Kym-001
12. Glxc-26797
13. Glxc-27930
14. Ex-a8217
15. Kt-i-417
16. Sar444656
17. At41570
18. Kt-474?
19. Sar-444656
20. Compound A [wo2022174269a1]
21. Da-77150
22. Hy-145483
23. Cs-0374973
24. 5-((1r,4r)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl)-n-(3-(difluoromethyl)-1-((1r,4r)-4-((4-((3-(1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxo-2,3-dihydro-1h-benzo[d]imidazol-4-yl)prop-2-yn-1-yl)oxy)piperidin-1-yl)methyl)cyclohexyl)-1h-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
25. Pyrazolo(1,5-a)pyrimidine-3-carboxamide, N-(3-(difluoromethyl)-1-(trans-4-((4-((3-(1-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-3-methyl-2-oxo-1h-benzimidazol-4-yl)-2-propyn-1-yl)oxy)-1-piperidinyl)methyl)cyclohexyl)-1h-pyrazol-4-yl)-5-(1r,4r)-2-oxa-5-azabicyclo(2.2.1)hept-5-yl-
| Molecular Weight | 865.9 g/mol |
|---|---|
| Molecular Formula | C44H49F2N11O6 |
| XLogP3 | 2.5 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 11 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 172 |
| Heavy Atom Count | 63 |
| Formal Charge | 0 |
| Complexity | 1790 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
99
PharmaCompass offers a list of KT-474 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right KT-474 manufacturer or KT-474 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred KT-474 manufacturer or KT-474 supplier.
PharmaCompass also assists you with knowing the KT-474 API Price utilized in the formulation of products. KT-474 API Price is not always fixed or binding as the KT-474 Price is obtained through a variety of data sources. The KT-474 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A KT-474 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of KT-474, including repackagers and relabelers. The FDA regulates KT-474 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. KT-474 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A KT-474 supplier is an individual or a company that provides KT-474 active pharmaceutical ingredient (API) or KT-474 finished formulations upon request. The KT-474 suppliers may include KT-474 API manufacturers, exporters, distributors and traders.
KT-474 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of KT-474 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right KT-474 GMP manufacturer or KT-474 GMP API supplier for your needs.
A KT-474 CoA (Certificate of Analysis) is a formal document that attests to KT-474's compliance with KT-474 specifications and serves as a tool for batch-level quality control.
KT-474 CoA mostly includes findings from lab analyses of a specific batch. For each KT-474 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
KT-474 may be tested according to a variety of international standards, such as European Pharmacopoeia (KT-474 EP), KT-474 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (KT-474 USP).
